RAD ONC MB 1 - Progress Notes (Physician) | 2022-01-29 14:30:00
Radiation Oncology Follow-Up    Name: ***** *****  *****: *****  DOB: 10/09/1954  Referring Physician: ***** ***** *****, MD   Primary Care Physician: ***** *****, MD   DOS:       01/29/22  CSN:       *****    Diagnosis:  (*****) Malignant neoplasm of base of tongue (CMS code)  (primary encounter diagnosis)  Cancer Staging  Malignant neoplasm of base of tongue (CMS code)  Staging form: Pharynx - HPV-Mediated Oropharynx, AJCC 8th Edition  - Clinical: Stage III (*****, *****, *****) - Signed by ***** *****-***** *****, MD on 10/16/2020      HPI  ***** ***** is a 67 y.o. male  never smoker diagnosed on 08/29/2020 with squamous cell carcinoma of the right base of tongue ***** ***** Stage III, s/p chemoradiation 70 Gy with weekly cisplatin 40 mg/m2 x 5 completed 12/23/2020. Pt has no other relevant hx. He was last seen on 10/09/21 and presents for follow-up.      Interval History:  10/09/21: Visit w/ Dr. *****-  Pt presented doing well with no definite signs of recurrence. Dr. ***** planned to follow a 3 mm LLL peripheral lung nodule.     11/11/21: FL Pharynx/Swallowing Eval w/ Fluoro-  IMPRESSION:   No aspiration.  For full details, please see the speech pathology report from the same date.     01/23/22: CT Chest w/o Contrast-  IMPRESSION:   No evidence of malignancy within the chest.    Today, he reports no issues with eating or drinking. He does have some sensation of throat irritation. He reports persistent changes in taste, about 50-60% of baseline. He often can't taste salt or sugar from ***** food or ***** food.     Review of Systems   Neurological: Positive for tingling.       Past Medical History:   Diagnosis Date    Anxiety     Cancer (CMS code) squamous cell carcinoma    Chronic kidney disease GFR 58    OSA (obstructive sleep apnea) 2005    New CPAP on April 2017    Renal insufficiency      Past Surgical History:   Procedure Laterality Date    COLONOSCOPY       Allergies/Contraindications   Allergen 
 Reactions    Glycopyrrolate Hives    Ondansetron Hcl      Current Outpatient Medications   Medication Sig Dispense Refill    fluoride, sodium, (***** 5000 BOOSTER PLUS) 1.1 % dental paste ***** TRACE AMOUNT ON TEETH TWICE DAILY. ***** OUT EXCESS. DO NOT EAT DRINK OR RINSE FOR 30 MINUTES. (Patient not taking: Reported on 01/29/2022  ) 100 mL 11     No current facility-administered medications for this encounter.     Social History     Tobacco Use   Smoking Status Never Smoker   Smokeless Tobacco Never Used            Vitals: BP 126/89  | Pulse 113  | Temp 37.2 C (98.9 F) (Temporal)  | Resp 18  | Wt 73 kg (160 lb 14.4 oz)  | SpO2 100%  | BMI 24.90 kg/m   Pain score:0   /10  Karnofsky Performance Status (KPS): 80% - Normal activity with some difficulty, some symptoms or signs    Physical Exam  General: Well nourished, in no acute distress, alert and interactive  Head: Normocephalic and atraumatic    Cranial nerves: II-XII intact  Face: Symmetric, no skin lesions, no sinus tenderness    Eyes: Sclera white, no conjunctival irritation or injection  Ears: External pinna normal, external auditory canals and tympanic membranes clear    Nose: External nose without lesions    Oral cavity: Good dentition, moist mucosa, no lesions on anterior tongue, good movement anterior tongue  Oropharynx: No mucosal lesions, no tonsillar enlargement, symmetric palate rise; Dry mouth  Neck: No fibrosis, no lymphedema, no hyperpigmentation. Supple, trachea midline, full active range of motion  Lymphatics: No cervical or supraclavicular lymphadenopathy.     Fiberoptic *****:  Indication: Requirement for full, in depth, close up view of upper aerodigestive tract.  Details:   After verbal consent, 4% lidocaine sprayed in the right naris. I advanced the flexible fiberoptic endoscope through the nose and into the nasal cavity.   Nasal Cavity: clear, no lesions, healthy mucosa  Nasopharynx: healthy mucosa, no lesions, 
   Oropharynx: clear, no lesions, healthy mucosa. Some edema at base of tongue  Larynx: Both true vocal folds are mobile, full abduction and adduction. No evidence of subglottic disease. Some pooling of saliva in vallecula.   Hypopharynx: piriform sinuses, posterior cricoid area, and posterior pharyngeal walls normal.     Pathology Studies: Personally reviewed, with findings as per HPI.    Laboratory Studies: Personally reviewed labs below.    WBC Count   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 3.5 3.4 - 10.0 x10E9/L Final     Hemoglobin   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 11.9 (L) 13.6 - 17.5 g/dL Final     Hematocrit   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 38.2 (L) 41.0 - 53.0 % Final     Platelet Count   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM ***** ***** - 450 x10E9/L Final      Urea Nitrogen, Serum / Plasma   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 26 (H) 7 - 25 mg/dL Final     Sodium, Serum / Plasma   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM ***** ***** - 145 mmol/L Final     Potassium, Serum / Plasma   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 4.6 3.5 - 5.0 mmol/L Final     Carbon Dioxide, Total   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 28 22 - 29 mmol/L Final     Chloride, Serum / Plasma   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM ***** ***** - 110 mmol/L Final     Glucose, non-fasting   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 104 70 - 199 mg/dL Final     Comment:     If the patient is fasting, suggests impaired glucose homeostasis     Calcium, total, Serum / Plasma   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 10.0 8.4 - 10.5 mg/dL Final     Magnesium, Serum / Plasma   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 2.1 1.6 - 2.6 mg/dL Final     Bilirubin, Total   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 0.2 0.2 - 1.2 mg/dL Final     AST 
   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 21 5 - 44 U/L Final     Alanine transaminase   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 19 10 - 61 U/L Final     Albumin, Serum / Plasma   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 4.0 3.4 - 4.8 g/dL Final      Thyroid Stimulating Hormone   Date/Time Value Ref Range Status   *****/*****/***** *****:***** PM 1.73 0.45 - 4.12 mIU/L Final       Radiology Studies: Personally reviewed as per HPI.       Assessment:  ***** ***** is a 67 y.o. male never smoker diagnosed on 08/29/2020 with squamous cell carcinoma of the right base of tongue ***** ***** Stage III, s/p chemoradiation 70 Gy with weekly cisplatin 40 mg/m2 x 5 completed 12/23/2020.     No evidence of residual or recurrent disease on imaging or exam. Discussed pilocarpine for dry mouth. Also discussed zinc supplementation for dysgeusia.     Last head and neck imaging: 10/03/2021  Last chest imaging: 01/23/2022  Last TSH: 1.73 03/11/2021    Plan:  - thyroid function testing every 6 months  - chest imaging *****  - assiduous dental care with ***** every 3-4 months  - pilocarpine for dry mouth, 5 mg three times a day but can start at a lower dose if desired  - zinc 50 mg twice a day with food for dysgeusia  - follow-up appointment in radiation oncology in 6 months with repeat CT neck and CT chest      Future Appointments   Date Time Provider Department Center   *****/*****/*****  *****:***** PM ***** ***** *****, MD OHNS HNS ***** PCMB            *****, ***** ***** am acting as a chart ***** for services provided by Dr. ***** ***** on 01/29/2022      

